CML differs from other myeloproliferative neoplasms because of the BCR-ABL1 fusion gene and Philadelphia chromosome (Ph) caused by t(9;22)(q34.1;q11.2) [2-4]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.